Lindsay Clark, PhD

Lindsay Clark, PhD

Image
dr lindsay clark

Assistant Professor

Department of Medicine
Division of Geriatrics and Gerontology

Education

BS, University of Illinois at Urbana-Champaign
MS, San Diego State University
PhD, San Diego State University/University of California, San Diego, Joint Doctoral Program in Clinical Psychology
APA-approved predoctoral internship, UCLA Semel Institute for Neuroscience and Human Behavior Adult Neuropsychology
Holland Postdoctoral Fellowship in Neuropsychology and Neuroimaging, Wisconsin Alzheimer’s Institute, University of Wisconsin
Advanced Fellowship in Geriatrics, Geriatric Research Education and Clinical Center (GRECC), William S Middleton Memorial Veterans Hospital

Professional Activities

Dr. Lindsay Clark is a faculty member in the Division of Geriatrics and Gerontology in the Department of Medicine. As a licensed neuropsychologist specializing in geriatrics, Dr. Clark provides diagnostic assessments, treatment planning, and supportive counseling in the UW Memory Assessment and Follow-up Clinics. She also serves as staff neuropsychologist in the Madison VA GRECC Teleneuropsychology Service and Cognitive Care Clinic. She is an investigator with the Wisconsin Alzheimer’s Disease Research Center (WARDC) and the Wisconsin Registry for Alzheimer’s Prevention (WRAP) and supports the WADRC neuropsychology service. Dr. Clark provides continuing medical education to clinicians on topics in geriatric neuropsychology, and clinical instruction to neuropsychology and psychology trainees. Dr. Clark is a member of the American Psychology Association Division 40 (Society for Clinical Neuropsychology) Scientific Advisory Committee, the International Neuropsychological Society, and the Alzheimer’s Association International Society to Advance Alzheimer’s Research & Treatment (ISTAART).

Research Interests

Dr. Clark's research interests include investigating relationships among Alzheimer's disease biomarkers (neuroimaging, CSF), midlife vascular risk factors, and cognitive decline, improving the reliability and ecological validity of measures to identify subtle cognitive decline, and developing strategies for safe disclosure of sensitive biomarker-related information to research participants and patients.